Skip to content
RDL
Network
Ecosystem
Switch app
TR
About
FAQ
Sign in
Get started
Extracorporeal apheresis therapy for Alzheimer disease—targeting lipids, stress, and inflammation — Stefan R. Bornstein (2019) | RDL Network
Back
Cite
Save
Save for later
Share
Home
Publications
Extracorporeal apheresis therapy for Alzheimer disease—targeting lipids, stress, and inflammation
Shared by
George Chrousos
National Technical University of Athens
Extracorporeal apheresis therapy for Alzheimer disease—targeting lipids, stress, and inflammation
Article
2019
en
Authors
+12 more
SB
Stefan R. Bornstein
KV
Karin Voit-Bak
PR
Peter Rosenthal
Discussion
(0)
Sign in
to like and join the discussion.
No comments yet. Be the first to comment.
Related publications
Chapter in a book
2016
Tackling Alzheimer’s Disease by Targeting Oxidative Stress and Mitochondria
Rudy J. Castellani
,
Sónia C. Correia
,
Paula I. Moreira
,
George Perry
Article
2024
Ferroptosis: A new strategy for targeting Alzheimer’s disease
Rong Qiang
,
Yang Xiang
,
Lei Zhang
,
Xin Yue Bai
,
Die Zhang
,
Yang Jing Li
,
Yan Yang
,
Xiao Long Liu
Article
2024
Targeting immunogenic cell stress and death for cancer therapy
Lorenzo Galluzzi
,
Emma Guilbaud
,
Darby Schmidt
,
Guido Guido Kroemer
,
Francesco M. Marincola
Chapter in a book
2016
Oxidative Stress and Alzheimer’s Disease
Sandeep Kumar Singh
,
Rudy J. Castellani
,
George Perry
Article
2002
Alzheimer Disease and Oxidative Stress
George Perry
,
Ayla Cash
,
Mark A. Smith
Discussion(0)
No comments yet. Be the first to comment.